NRG1, PIP4K2A, and HTR2C as Potential Candidate Biomarker Genes for Several Clinical Subphenotypes of Depression and Bipolar Disorder

por Levchenko, Anastasia, Vyalova, Natalia M., Nurgaliev, Timur, Pozhidaev, Ivan V., Simutkin, German G., Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2020

PM515. The association between serotonin receptor gene polymorphisms and hyperprolactinemia in antipsychotic drug-treated schizophrenic patients

por Ivanova, Svetlana, Boiko, Anastasia, Bokhan, Nikolay, Fedorenko, Olga, Freidin, Maxim, Loonen, Anton, Osmanova, Diana, Pozhidaev, Ivan, Semke, Arkadiy, Wilffert, Bob
Publicado 2016

Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia

por Fedorenko, Olga Yu., Paderina, Diana Z., Loonen, Anton J. M., Pozhidaev, Ivan V., Boiko, Anastasiia S., Kornetova, Elena G., Bokhan, Nikolay A., Wilffert, Bob, Ivanova, Svetlana A.
Publicado 2020

5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia

por Pozhidaev, Ivan V., Paderina, Diana Z., Fedorenko, Olga Yu., Kornetova, Elena G., Semke, Arkadiy V., Loonen, Anton J. M., Bokhan, Nikolay A., Wilffert, Bob, Ivanova, Svetlana A.
Publicado 2020

Limited Associations Between 5-HT Receptor Gene Polymorphisms and Treatment Response in Antidepressant Treatment-Free Patients With Depression

por Ochi, Taichi, Vyalova, Natalya M., Losenkov, Innokentiy S., Paderina, Diana Z., Pozhidaev, Ivan V., Loonen, Anton J. M., Simutkin, German G., Bokhan, Nikolay A., Ivanova, Svetlana A., Wilffert, Bob
Publicado 2019

Preliminary Pharmacogenetic Study to Explore Putative Dopaminergic Mechanisms of Antidepressant Action

por Ochi, Taichi, Vyalova, Natalya M., Losenkov, Innokentiy S., Paderina, Diana Z., Pozhidaev, Ivan V., Loonen, Anton J. M., Simutkin, German G., Bokhan, Nikolay A., Wilffert, Bob, Ivanova, Svetlana A.
Publicado 2021

The Role of Glutamatergic Gene Polymorphisms in the Clinical Phenotypes of Schizophrenia

por Poltavskaya, Evgeniya G., Kornetova, Elena G., Freidin, Maxim B., Pozhidaev, Ivan V., Paderina, Diana Z., Bocharova, Anna V., Semke, Arkadiy V., Bokhan, Nikolay A., Ivanova, Svetlana A., Fedorenko, Olga Y.
Publicado 2023

Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia

por Pozhidaev, Ivan V, Boiko, Anastasiia S, Loonen, Anton J M, Paderina, Diana Z, Fedorenko, Olga Yu, Tenin, Gennadiy, Kornetova, Elena G, Semke, Arkadiy V, Bokhan, Nikolay A, Wilffert, Bob, Ivanova, Svetlana A
Publicado 2020

Genetic Polymorphisms of 5-HT Receptors and Antipsychotic-Induced Metabolic Dysfunction in Patients with Schizophrenia

por Paderina, Diana Z., Boiko, Anastasiia S., Pozhidaev, Ivan V., Bocharova, Anna V., Mednova, Irina A., Fedorenko, Olga Yu., Kornetova, Elena G., Loonen, Anton J.M., Semke, Arkadiy V., Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2021

Comparative Characteristics of the Metabolic Syndrome Prevalence in Patients With Schizophrenia in Three Western Siberia Psychiatric Hospitals

por Kornetova, Elena G., Kornetov, Alexander N., Mednova, Irina A., Goncharova, Anastasia A., Gerasimova, Valeria I., Pozhidaev, Ivan V., Boiko, Anastasiia S., Semke, Arkadiy V., Loonen, Anton J. M., Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2021

Search for Possible Associations of FTO Gene Polymorphic Variants with Metabolic Syndrome, Obesity and Body Mass Index in Schizophrenia Patients

por Boiko, Anastasiia S, Pozhidaev, Ivan V, Paderina, Diana Z, Bocharova, Anna V, Mednova, Irina A, Fedorenko, Olga Yu, Kornetova, Elena G, Loonen, Anton J M, Semke, Arkadiy V, Bokhan, Nikolay A, Ivanova, Svetlana A
Publicado 2021

Gene Polymorphisms of Hormonal Regulators of Metabolism in Patients with Schizophrenia with Metabolic Syndrome

por Boiko, Anastasiia S., Pozhidaev, Ivan V., Paderina, Diana Z., Mednova, Irina A., Goncharova, Anastasya A., Fedorenko, Olga Yu., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.
Publicado 2022

Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment‐free Russian patients with moderate or severe depression: An explorative psyc...

por Geers, Lisanne M., Ochi, Taichi, Vyalova, Natalya M., Losenkov, Innokentiy S., Paderina, Diana Z., Pozhidaev, Ivan V., Simutkin, German G., Bokhan, Nikolay A., Wilffert, Bob, Touw, Daniël J., Loonen, Anton J.M., Ivanova, Svetlana A.
Publicado 2021

Genes of the Glutamatergic System and Tardive Dyskinesia in Patients with Schizophrenia

por Fedorenko, Olga Yu., Paderina, Diana Z., Kornetova, Elena G., Poltavskaya, Evgeniya G., Pozhidaev, Ivan V., Goncharova, Anastasiia A., Freidin, Maxim B., Bocharova, Anna V., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.
Publicado 2022

The Gender-Specific Association of DRD2 Polymorphism with Metabolic Syndrome in Patients with Schizophrenia

por Paderina, Diana Z., Boiko, Anastasiia S., Pozhidaev, Ivan V., Mednova, Irina A., Goncharova, Anastasia A., Bocharova, Anna V., Fedorenko, Olga Yu., Kornetova, Elena G., Semke, Arkadiy V., Bokhan, Nikolay A., Loonen, Anton J. M., Ivanova, Svetlana A.
Publicado 2022

A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia

por Osmanova, Diana Z., Freidin, Maxim B., Fedorenko, Olga Yu., Pozhidaev, Ivan V., Boiko, Anastasiia S., Vyalova, Natalia M., Tiguntsev, Vladimir V., Kornetova, Elena G., Loonen, Anton J. M., Semke, Arkadiy V., Wilffert, Bob, Bokhan, Nikolay A., Ivanova, Svetlana A.
Publicado 2019

Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia

por Geers, Lisanne M., Pozhidaev, Ivan V., Ivanova, Svetlana A., Freidin, Maxim B., Schmidt, Amand F., Cohen, Dan, Boiko, Anastasiia S., Paderina, Diana Z., Fedorenko, Olga Yu, Semke, Arkadiy V., Bokhan, Nikolay A., Wilffert, Bob, Kosterink, Jos G.W., Touw, Daan J., Loonen, Anton J.M.
Publicado 2020